CSTL logo

CSTL

Castle Biosciences Inc.

$24.01
+$0.55(+2.34%)
27
Overall
--
Value
27
Tech
--
Quality
Market Cap
$619.33M
Volume
518.80K
52W Range
$14.59 - $35.84
Target Price
$36.11
Order:

Income Statement

MetricTrendChart
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$51.9M$62.6M$94.1M$137.0M$219.8M$332.1M
Total Revenue
$51.9M$62.6M$94.1M$137.0M$219.8M$332.1M
COST OF GOODS SOLD
Cost of Revenue
$7.3M$9.7M$15.8M$32.0M$45.0M$60.2M
GROSS PROFIT
Gross Profit
$44.6M$53.0M$78.3M$105.0M$174.8M$271.9M
OPERATING EXPENSES
Operating Expenses
$39.4M$59.5M$134.2M$196.2M$242.8M$263.2M
Research & Development
$9.5M$13.3M$45.5M$44.9M$53.6M$52.0M
Research Expense
$9.5M$13.3M$29.6M$44.9M$53.6M$52.0M
Selling, General & Administrative
$29.8M$48.1M$86.7M$143.0M$180.2M$200.0M
General & Administrative Expenses
$29.8M$48.1M$86.7M$143.0M$180.2M$200.0M
Depreciation & Amortization
$-354.0K$472.0K$2.0M$8.3M$9.0M$11.1M
Depreciation & Amortization
$2.2M$472.0K$2.0M$8.3M$9.0M$11.1M
Amortization
$-1.9M$839.0K$2.0M$8.3M$9.0M$11.1M
Other Operating Expenses
--$-1.9M$1.5M------
OPERATING INCOME
Operating income
$5.2M$-6.5M$-40.1M$-72.9M$-68.0M$8.7M
EBITDA
$10.0M$-7.1M$-36.6M$-58.3M$-45.0M$38.1M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$4.6M$2.6M$1.0K$17.0K$11.0K$577.0K
Interest Income Operating
$420.0K----------
Intinc
$312.0K$373.0K$68.0K$4.0M$10.6M$12.9M
Net Non-Operating Interest Income/Expense
$-4.3M$-2.3M$67.0K$-4.0M$10.6M$12.3M
Other Income/Expense
$-2.3M$1.4M--$18.3M--$-600.0K
Other Special Charges
$2.3M$-1.4M--------
PRE-TAX INCOME
EBIT
$7.8M$-7.6M$-40.0M$-68.9M$-57.4M$22.1M
Pre-Tax Income
$3.2M$-10.2M$-40.1M$-68.9M$-57.4M$21.6M
INCOME TAX
Tax Provision
$72.0K$84.0K$-8.7M$-1.8M$101.0K$3.3M
NET INCOME
Net Income
$3.1M$-10.3M$-31.3M$-67.1M$-57.5M$18.2M
Net Income (Continuing Operations)
$3.1M$-10.3M$-31.3M$-67.1M$-57.5M$18.2M
Net Income (Discontinued Operations)
$3.1M$-10.3M$-31.3M$-67.1M$-57.5M$18.2M
Net Income (Common Stockholders)
$3.0M$-10.3M$-31.3M$-67.1M$-57.5M$18.2M
Normalized Income
----$-48.8M------
TOTALS
Total Expenses
$46.7M$69.2M$150.0M$228.2M$287.8M$323.4M
SHARE & EPS DATA
Average Shares Outstanding
$8.6M$18.9M$25.1M$26.1M$26.8M$27.8M
Average Shares Outstanding (Diluted)
$8.7M$18.9M$25.1M$26.1M$26.8M$29.3M
Shares Outstanding
$17.2M$25.0M$29.0M$26.6M$27.4M$28.5M
Basic EPS
$0.35$-0.54$-1.24$-2.58$-2.14$0.66
Basic EPS (Continuing Operations)
$0.35$-0.54$-1.24$-2.58$-2.14$0.66
Diluted EPS
$-0.21$-0.54$-1.24$-2.58$-2.14$0.62
Diluted EPS (Continuing Operations)
$-0.21$-0.54$-1.24$-2.58$-2.14$0.62
OTHER METRICS
Accretion On Preferred Stock
$130.0K----------
Depletion
$2.2M----------
Development Expense
----$15.8M------
Other Gand A
$29.8M$48.1M$86.7M$143.0M$180.2M$200.0M
Otherunder Preferred Stock Dividend
$130.0K----------
Preferred Stock Dividends
$130.0K----------
Rent And Landing Fees
$-395.0K$548.0K--------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2CSTL$24.01+2.3%518.80K
3
4
5
6

Get Castle Biosciences Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.